Cargando…

Induction of PARP7 Creates a Vulnerability for Growth Inhibition by RBN2397 in Prostate Cancer Cells

The ADP-ribosyltransferase PARP7 modulates protein function by conjugating ADP-ribose to the side chains of acceptor amino acids. PARP7 has been shown to affect gene expression in prostate cancer cells and certain other cell types by mechanisms that include transcription factor ADP-ribosylation. Her...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Chunsong, Wierbiłowicz, Krzysztof, Dworak, Natalia M., Bae, Song Yi, Tengse, Sachi B., Abianeh, Nicki, Drake, Justin M., Abbas, Tarek, Ratan, Aakrosh, Wotton, David, Paschal, Bryce M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Association for Cancer Research 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10108886/ https://www.ncbi.nlm.nih.gov/pubmed/37077937 http://dx.doi.org/10.1158/2767-9764.CRC-23-0086

Ejemplares similares

Layered polymeric nitrogen in RbN(3) at high pressures
por: Wang, Xiaoli, et al.
Publicado: (2015)

Excitatory/inhibitory balance emerges as a key factor for RBN performance, overriding attractor dynamics
por: Calvet, Emmanuel, et al.
Publicado: (2023)

2397. Effects of antimicrobial surgical prophylaxis on rates of Clostridioides difficile infection
por: Hayes, Sarah K, et al.
Publicado: (2019)

Synthetic Dual Cysteine-ADP Ribosylated Peptides from the Androgen Receptor are Recognized by the DTX3L/PARP9 Complex
por: Wijngaarden, Sven, et al.
Publicado: (2023)

Genomic analysis of DNA repair genes and androgen signaling in prostate cancer
por: Jividen, Kasey, et al.
Publicado: (2018)

Post-Transcriptional Regulation of PARP7 Protein Stability Is Controlled by Androgen Signaling
por: Kamata, Teddy, et al.
Publicado: (2021)

GR-2397: Review of the Novel Siderophore-like Antifungal Agent for the Treatment of Invasive Aspergillosis
por: Shaw, Karen Joy
Publicado: (2022)

Pharmacokinetic-Pharmacodynamic Target Attainment Analysis to Support VL-2397 Dose Selection for a Phase 2 Trial in Patients with Invasive Aspergillosis
por: Rubino, Christopher M, et al.
Publicado: (2017)

2397: A checklist for developing and implementing a high-impact monitoring and evaluation system in clinical and translational science programs
por: Volkov, Boris
Publicado: (2018)

2397. Infective Endocarditis is Associated With Higher Mortality and Worse Clinical Outcomes in Patients Hospitalized with a Concomitant Diagnosis of Heart Failure
por: Sharath, Deepali Boothankad, et al.
Publicado: (2023)

SVXplorer: Three-tier approach to identification of structural variants via sequential recombination of discordant cluster signatures
por: Kathuria, Kunal, et al.
Publicado: (2020)

Protocol for integrative subtyping of lower-grade gliomas using the SUMO pipeline
por: Sienkiewicz, Karolina, et al.
Publicado: (2022)

Androgen signaling uses a writer and a reader of ADP-ribosylation to regulate protein complex assembly
por: Yang, Chun-Song, et al.
Publicado: (2021)

Novel deletion and 2397 G>T mutations of the EXT1 gene identified in two Chinese pedigrees with hereditary multiple exostoses using exon sequencing
por: Shen, Yang, et al.
Publicado: (2020)

Neurobiology of opioid dependence in creating addiction vulnerability
por: Evans, Christopher J., et al.
Publicado: (2016)

Germline variants predictive of tumor mutational burden and immune checkpoint inhibitor efficacy
por: Chatrath, Ajay, et al.
Publicado: (2021)

Integrated bioinformatic pipeline using whole-exome and RNAseq data to identify germline variants correlated with cancer
por: Sahu, Divya, et al.
Publicado: (2022)

Sims and Vulnerability: On the Ethics of Creating Emulated Minds
por: Chomanski, Bartlomiej
Publicado: (2022)

Implementation of a Hamming distance–like genomic quantum classifier using inner products on ibmqx2 and ibmq_16_melbourne
por: Kathuria, Kunal, et al.
Publicado: (2020)

Targeting therapeutic vulnerabilities with PARP inhibition and radiation in IDH-mutant gliomas and cholangiocarcinomas
por: Wang, Yuxiang, et al.
Publicado: (2020)

Therapeutic vulnerability to PARP1,2 inhibition in RB1-mutant osteosarcoma
por: Zoumpoulidou, Georgia, et al.
Publicado: (2021)

TP53 loss creates therapeutic vulnerability in colorectal cancer
por: Liu, Yunhua, et al.
Publicado: (2015)

Calling SNPs without a reference sequence
por: Ratan, Aakrosh, et al.
Publicado: (2010)

Activation of Akt Signaling in Prostate Induces a TGFβ Mediated Restraint on Cancer Progression and Metastasis
por: Bjerke, Glen A., et al.
Publicado: (2013)

Identification of indels in next-generation sequencing data
por: Ratan, Aakrosh, et al.
Publicado: (2015)

A survey on etiopathological correlation of Krimi (intestinal helminths) and Pandu (anemia)
por: Tengse, V. G., et al.
Publicado: (2011)

Integrated proteomics identifies PARP inhibitor-induced prosurvival signaling changes as potential vulnerabilities in ovarian cancer
por: Deng, Ou, et al.
Publicado: (2022)

Creating and Evaluating Two Cumulative Developmental Vulnerability Risk Measures.
por: Duku, Eric, et al.
Publicado: (2022)

Accessibility of covariance information creates vulnerability in Federated Learning frameworks
por: Huth, Manuel, et al.
Publicado: (2023)

A massively parallel strategy for STR marker development, capture, and genotyping
por: Kistler, Logan, et al.
Publicado: (2017)

Prostate Cancer Induced by Loss of Apc Is Restrained by TGFβ Signaling
por: Bjerke, Glen A., et al.
Publicado: (2014)

2397. Comparing Predictive Performance of INCREMENT Scores on Mortality Among Patients With Carbapenem-Non-Susceptible (CNS) Klebsiella pneumoniae (Kp) and Enterobacter cloacae Complex (Ecc) Bloodstream Infections (BSI) in the Veterans Health Administration (VHA)
por: El Chakhtoura, Nadim G, et al.
Publicado: (2018)

A nuclear lamina‐chromatin‐Ran GTPase axis modulates nuclear import and DNA damage signaling
por: Dworak, Natalia, et al.
Publicado: (2018)

Comparison of Sequencing Platforms for Single Nucleotide Variant Calls in a Human Sample
por: Ratan, Aakrosh, et al.
Publicado: (2013)

Drug resistance mechanisms create targetable proteostatic vulnerabilities in Her2+ breast cancers
por: Singh, Navneet, et al.
Publicado: (2022)

Mono-ADP-ribosylation by PARP10 and PARP14 in genome stability
por: Dhoonmoon, Ashna, et al.
Publicado: (2023)

Clinical PARP inhibitors allosterically induce PARP2 retention on DNA
por: Langelier, Marie-France, et al.
Publicado: (2023)

Immunomodulatory Roles of PARP-1 and PARP-2: Impact on PARP-Centered Cancer Therapies
por: Yélamos, José, et al.
Publicado: (2020)

PARP Power: A Structural Perspective on PARP1, PARP2, and PARP3 in DNA Damage Repair and Nucleosome Remodelling
por: van Beek, Lotte, et al.
Publicado: (2021)

N-Myc-induced metabolic rewiring creates novel therapeutic vulnerabilities in neuroblastoma
por: Tjaden, Britta, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ptghfhkkiobhjkbejgg6j8tvlm